JP2010532657A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532657A5
JP2010532657A5 JP2010504730A JP2010504730A JP2010532657A5 JP 2010532657 A5 JP2010532657 A5 JP 2010532657A5 JP 2010504730 A JP2010504730 A JP 2010504730A JP 2010504730 A JP2010504730 A JP 2010504730A JP 2010532657 A5 JP2010532657 A5 JP 2010532657A5
Authority
JP
Japan
Prior art keywords
nucleic acid
antigen
acid molecule
fragment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010504730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010532657A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/055214 external-priority patent/WO2008135446A2/en
Publication of JP2010532657A publication Critical patent/JP2010532657A/ja
Publication of JP2010532657A5 publication Critical patent/JP2010532657A5/ja
Pending legal-status Critical Current

Links

JP2010504730A 2007-05-02 2008-04-29 クレブシエラ属の抗原 Pending JP2010532657A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07107344 2007-05-02
PCT/EP2008/055214 WO2008135446A2 (en) 2007-05-02 2008-04-29 Klebsiella antigens

Publications (2)

Publication Number Publication Date
JP2010532657A JP2010532657A (ja) 2010-10-14
JP2010532657A5 true JP2010532657A5 (enExample) 2011-07-14

Family

ID=39708006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504730A Pending JP2010532657A (ja) 2007-05-02 2008-04-29 クレブシエラ属の抗原

Country Status (7)

Country Link
US (3) US8236326B2 (enExample)
EP (5) EP2152731A2 (enExample)
JP (1) JP2010532657A (enExample)
CN (1) CN102015754A (enExample)
AU (1) AU2008248755A1 (enExample)
CA (1) CA2685805A1 (enExample)
WO (1) WO2008135446A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2152731A2 (en) * 2007-05-02 2010-02-17 Intercell AG Klebsiella antigens
EP2326662B1 (en) * 2008-08-28 2016-11-23 The University Of Queensland Mutant bacterial glycoproteins and uses thereof
US9169477B2 (en) 2012-01-27 2015-10-27 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for immunization against bacteria expressing a carbapenemase
KR101605846B1 (ko) * 2013-11-20 2016-03-23 한국과학기술연구원 클렙시엘라 뉴모니아에 특이적으로 결합하는 단일가닥 핵산 앱타머 및 이를 이용한 클렙시엘라 뉴모니아 검출 방법
US10434162B2 (en) 2015-01-12 2019-10-08 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
MX2018000395A (es) * 2015-07-10 2018-05-23 Epitopix Llc Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
HK1252350A1 (zh) * 2015-08-24 2019-05-24 Medimmune, Llc Mrka多肽、抗体及其用途
EP3368564A1 (en) * 2015-10-28 2018-09-05 ARSANIS Biosciences GmbH Antibodies targeting a mannan-based o-antigen of k. pneumoniae
AU2017306709A1 (en) 2016-08-05 2019-03-14 Humabs, BioMed SA Anti-o2 antibodies and uses thereof
EP3497124A1 (en) * 2016-08-12 2019-06-19 ARSANIS Biosciences GmbH Klebsiella pneumoniae o3 specific antibodies
SG11201903063UA (en) 2016-10-19 2019-05-30 Medimmune Llc Anti-o1 antibodies and uses thereof
CN110540595B (zh) * 2018-12-20 2021-04-06 湖北工业大学 一种肺炎克雷伯菌抗体乳胶微球免疫层析检测试纸的制备方法
CN110540599B (zh) * 2018-12-20 2021-04-06 湖北工业大学 基于肺炎克雷伯菌表面蛋白抗体的肺炎克雷伯菌Elisa检测试剂盒及制备方法
CN110540600B (zh) * 2018-12-20 2021-01-29 湖北工业大学 基于肺炎克雷伯菌表面蛋白的乳胶微球免疫层析试纸的制备方法
CN111150839A (zh) * 2019-12-17 2020-05-15 中国科学院深圳先进技术研究院 一种用于免疫接种的组合物及其制备方法
CN112505324A (zh) * 2020-11-06 2021-03-16 杭州迅耀生物科技有限公司 一种新型冠状病毒检测方法
CN116033922B (zh) * 2021-08-25 2025-08-19 北京三诺佳邑生物技术有限责任公司 特异性识别肺炎克雷伯菌o1抗原的抗体及其应用
CN115838431A (zh) * 2022-07-08 2023-03-24 中国人民解放军陆军军医大学 一种用作肺炎克雷伯菌疫苗抗原的融合蛋白KP-Ag2及其应用
WO2025177313A1 (en) * 2024-02-23 2025-08-28 Bharat Serums And Vaccines Limited Antibodies against klebsiella pneumoniae and implementations thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
AU7906691A (en) 1990-05-23 1991-12-10 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Adeno-associated virus (aav)-based eucaryotic vectors
KR970002255B1 (ko) 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
ATE169030T1 (de) 1990-06-28 1998-08-15 Hoechst Ag Fusionsproteine mit immunglobulinanteilen, ihre herstellung und verwendung
WO1996002555A1 (en) 1994-07-15 1996-02-01 The University Of Iowa Research Foundation Immunomodulatory oligonucleotides
CO4600681A1 (es) 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria
AU743469C (en) 1996-08-30 2004-02-12 Rolf Bald Mirror-symmetrical selection and evolution of nucleic acids
US5989912A (en) 1996-11-21 1999-11-23 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
ATE375169T1 (de) 2000-04-14 2007-10-15 Intercell Ag Modifizierte peptide enthaltende pharmazeutische präparationen
AT410173B (de) * 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
WO2001093905A1 (en) * 2000-06-08 2001-12-13 Intercell Biomedizinische Forschungs- Und Entwicklungs Ag Immunostimulatory oligodeoxynucleotides
AU2001289813B2 (en) 2000-08-17 2005-07-28 Intercell Ag A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
CA2448031A1 (en) 2001-05-21 2002-11-28 Intercell Ag Method for stabilising of nucleic acids
CA2452909A1 (en) 2001-12-07 2003-06-13 Intercell Ag Immunostimulatory oligodeoxynucleotides
WO2005103073A2 (en) * 2004-04-27 2005-11-03 Intercell Ag Td antigens
EP2152731A2 (en) * 2007-05-02 2010-02-17 Intercell AG Klebsiella antigens
DE102012005675A1 (de) 2012-03-21 2013-09-26 Daimler Ag Kraftfahrzeugantriebsstrangvorrichtung mit einem Mehrgruppengetriebe

Similar Documents

Publication Publication Date Title
JP2011004753A5 (enExample)
JP2008525033A5 (enExample)
CA2532369C (en) Immunogenic compositions for streptococcus pyogenes
Sagawa et al. The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region
JP2008538183A5 (enExample)
JP2020031658A5 (enExample)
JP2002531522A5 (enExample)
JP2002537791A5 (enExample)
JP2003527079A5 (enExample)
JP2004504808A5 (enExample)
JP2008508859A5 (enExample)
JP2018537087A5 (enExample)
JP2009540801A5 (enExample)
JP2004511201A5 (enExample)
JP2005511076A5 (enExample)
King et al. Achieving cross-reactivity with pan-ebolavirus antibodies
CN104844712A (zh) 肺炎链球菌蛋白抗原及其制备方法和应用
Azimova et al. Study of the Immunogenicity of Combination of Recombinant RBD (Omicron) and Nucleocapsid Proteins of SARS-CoV-2 Expressed in Pichia Pastoris
CN101378781B (zh) 制造免疫球蛋白的组合物和方法
US9267947B2 (en) Compositions and methods for preventing or treating Burkholderia infection
JP2008545381A5 (enExample)
JP2004535161A5 (enExample)
US7618635B2 (en) Super-antigen fusion proteins and the use thereof
JP2008517918A5 (enExample)
JP4005633B2 (ja) Ｆ型ボツリヌス毒素およびその用途